Nutraceuticals like glutamine, amino acids, and creatine may enhance recovery and performance when used to complement consistent nutrition and resistance training
Antiinflammatory actions of glucagon-like peptide-1based therapies beyond metabolic benefits Text PDF Abstract Therapies based on glucagon-like peptide-1 (GLP-1) reduce rates of cardiovascular and chronic kidney disease in people with type 2 diabetes and/or obesity, with ongoing clinical trials investigating their effects in people with metabolic liver disease, arthritis, and both substance use and neurodegenerative disorders
The faster the weight loss, the more collagen is lost. Despite volume loss being the skin side effect dominating the public discourse, there are other, less-discussed changessuch as dryness and dullnessthat most people on a GLP-1 experience
We continue to advocate for funding stability and policy support to ensure families maintain access to high-integrity, truly better-for-you products during periods of federal uncertainty. GLP-1 users are more focused on science and labels One in eight Americans has used a GLP-1 drug like Ozempic, Wegovy or Mounjaro, and this could rise to up to 70 million people by 2028, when theyll likely have boosted the national GDP by 1%
